Skip to main content
. 2012 Mar;28(3):282–288. doi: 10.1089/aid.2011.0057

Table 3.

Overall Incidence Rates of First-Time Infections for Categories with Four or More First Events Among Patients Enrolled in NISDI Compared with PACTG 219C

 
NISDIa
PACTG 219C3
 
Category Incident events Person Years IR of events/100 person years (95% CI) Incident events Person Years IR of events/100 person years (95% CI) pb
Overall first infectionsc 383 1633 23.45 (21.10–25.80)  
Bacterial pneumonia 170 2174 7.82 (6.64–8.99) 123 5726 2.15 (1.79–2.56) <0.001
Varicella 71 2385 2.98 (2.28–3.67) 29 6623 0.44 (0.29–0.63) <0.001
Dermatophyte infections 69 2409 2.86 (2.19–3.54) 57 6483 0.88 (0.67–1.14) <0.001
Herpes simplex virus 60 2440 2.46 (1.84–3.08) 11 7807 0.14 (0.07–0.25) <0.001
Herpes zoster 45 2460 1.83 (1.29–2.36) 77 6925 1.11 (0.88–1.39) 0.02
Abscess, bacterialc 37 2448 1.51 (1.02–2.00)  
Oral candidiasis 36 2466 1.46 (0.98–1.94) 52 5576 0.93 (0.70–1.22) 0.06
Molluscum contagiosum 31 2461 1.26 (0.82–1.70) 23 7392 0.31 (0.20–0.47) <0.001
Lymphadenitis 22 2495 0.88 (0.51–1.25) 7 7849 0.09 (0.04–0.18) <0.001
Urinary tract infection 19 2509 0.76 (0.42–1.10) 27 7660 0.35 (0.23–0.51) 0.03
Infectious diarrhea 18 2497 0.72 (0.39–1.05) 9 7552 0.12 (0.05–0.23) <0.001
P. jiroveci pneumonia 9 2526 0.36 (0.12–0.59) 7 7668 0.09 (0.04–0.19) 0.03
Lymphoid interstitial pneumonitis 7 2533 0.28 (0.07–0.48) 6 6889 0.09 (0.03–0.19) 0.09
Bacterial meningitisc 7 2522 0.28 (0.07–0.48)  
Tuberculosis (TB) 7 2523 0.28 (0.07–0.48) <4  
Viral hepatitis 6 2525 0.24 (0.05–0.43) 11 7729 0.14 (0.07–0.25) 0.37
Bacteremia/septicemia 5 2529 0.20 (0.02–0.37) 25 7192 0.35 (0.22–0.51) 0.18
CMV not retinitisc 4 2534 0.16 (0.0–0.31)  
a

NISDI reported <4 events for toxoplasmosis (3), non-TB mycobacteria (2), esophageal or pulmonary candidiasis (2), Cryptosporidium (2)c, progressive multifocal leukoencephalopathy (2)c, CMV retinitis (1), encephalitis (1)c, septic arthritis, bacterial (1)c.

b

Fisher's exact test.

c

Not reported in PACTG 219C.3

IR, incidence rate; CMV, cytomegalovirus.